Emblica officinalis - Anti-obesity activity.
Iram Nazish1, Shahid H Ansari2
1Department of Pharmacology, HK College of Pharmacy, Oshiwara, Mumbai, India.
Aqueous Emblica officinalis extract significantly reduced weight gain and improved lipid profiles in obese rats. This study highlights amla
Area of Science:
- Phytochemistry
- Pharmacology
- Obesity Research
Background:
- Emblica officinalis (amla) is widely used in traditional Indian medicine.
- Ethanolic extracts of E. officinalis show antidiabetic, antihyperlipidemic, and antioxidant effects.
- The anti-obesity potential of aqueous E. officinalis extract requires investigation.
Purpose of the Study:
- To evaluate the anti-obesity effects of aqueous Emblica officinalis extract.
- To assess the impact of the extract on weight gain and metabolic parameters in a high-fat diet-induced obesity model.
Main Methods:
- Male Wistar rats were fed a high-fat diet (HFD) for 42 days to induce obesity.
- Aqueous E. officinalis extract (20 mg/kg) was administered orally to HFD-fed rats for 42 days.
- Body weight gain, serum lipids, insulin, and leptin levels were measured.
Main Results:
- Aqueous E. officinalis extract significantly reduced body weight gain in HFD-induced obese rats.
- The extract led to significant reductions in serum insulin, leptin, and lipid levels.
- High-density lipoprotein cholesterol (HDL-C) levels were significantly increased by the extract.
Conclusions:
- Aqueous Emblica officinalis extract demonstrates significant anti-obesity potential.
- The extract may be beneficial in managing obesity and related metabolic disorders.
- Further research is warranted to elucidate the mechanisms of action.
More Related Videos
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
06:12Using Multiple Light Scattering to Examine the Stability of Phyllanthus emblica L. Extracts Obtained with Different Extraction Methods
Published on: April 14, 2023
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Obesity
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Drug Dosing: Obese Patients
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Cancer Prevention
Some...
